The first clinical trial of this technology had been completed early this year, and results from this study demonstrated a significantly improved adenoma detection rate (ADR) in the AI-aided group. Full results from this first clinical trial were presented at the United European Gastroenterology Week 2018 in Vienna last week by the authors of the Nature Biomedical Engineering publication, and Pu Wang, MD, a gastroenterologist at Sichuan Provincial Hospital, received the National Scholar Award for this cutting-edge research.
About Wision AI
Ad Statistics
Times Displayed: 112999
Times Visited: 6736 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
Shanghai Wision AI Co., Ltd is a leader in developing computer-aided diagnostic algorithms and systems to improve the accuracy and effectiveness of diagnostic imaging. Based in Shanghai, China, the company has extensive expertise in mathematics, algorithm development and software and hardware engineering and works closely with top-tier medical institutions in China and around the world. The company integrates medical knowledge into flexible and scalable models that leverage cutting-edge convolutional neural network and general-purpose computing to achieve high sensitivity and specificity in detection, segmentation and measurement in diagnostic imaging. Wision AI is advancing its transformative mathematical medicine approach in multiple clinical settings, including gastroenterology, ophthalmology, neurology, and radiomics. To learn more about Wision AI, go to http://www.wision.com/
Back to HCB News
